NewsFirst CE Mark for Patient Kits as Medical Devices Obtained by MedTrace First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace CEO Ann Kristin Led and CTO Lars Trolle in front of MedTrace’s automated...
NewsShrinking the Manufacturing Footprint with PET Point-of-CareShrinking the Manufacturing Footprint with PET Point-of-Care Jared Driskill, Sr. Medical Advisor at MedTrace “Today, most PET radiopharmaceuticals are produced at centralized locations and distributed....
NewsThe First Scientific Article Based on a MedTrace-Sponsored Study Has Been PublishedThe First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published MedTrace is proud to see the methodology paper “Rationale and design of the...
NewsMedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical TrialMedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical Trial Installation of MedTrace’s point-of-care manufacturing system, P3 MT-100....
NewsMedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTraceMedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTrace Ann Kristin Led Pharmaceutical and medical device company...
NewsNew Research Concludes That 15O-Water PET Can Be Used to Assess Blood Flow of the Right VentricleNew Research Concludes That 15O-Water PET Can Be Used to Assess Blood Flow of the Right Ventricle At MedTrace we keep a close eye on...
NewsMedTrace Is Proud to Sponsor the Women in Nuclear Cardiology Event at ASNC2023MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023 MedTrace is showcasing its technology and Phase 3 Clinical Trial at ASNC2023,...
NewsMedTrace Receives an 18 Million Euro Investment for Completion of Its Phase 3 TrialMedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed...
News15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System 15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and...
ClinicalNewsMedTrace Hosts 15O-Water Symposium for Nuclear Medicine ProfessionalsMedTrace hosts 15O-water symposium for nuclear medicine professionals 15O-water: Ready for the Future. Vol. 2. The symposium, sponsored by MedTrace, will take place on September...
NewsMedTrace Expands Patent Portfolio and Protects Its 15O-Water TechnologyMedTrace Expands Patent Portfolio and Protects Its 15O-Water Technology The new patent protects how the company’s automated manufacturing system, P3 MT-100, produces and doses the...
NewsMedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual MeetingMedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting MedTrace Pharma is proud to participate with a clinical booth and share the...
ClinicalNewsMedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical DevicesMedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices MedTrace is now ISO 13485 certified for the company’s quality management system in medical...
ClinicalNewsFirst U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 TrialFirst U.S. Patient Scanned in MedTrace’s 15O-Water Phase 3 Trial The first U.S. patient in MedTrace’s phase 3 clinical trial has been dosed and scanned...
ClinicalNewsNew Findings from Aarhus University Hospital Shed Light on How 15O-Water PET MPI May Benefit Patients with Bypass SurgeryNew findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery 15O-water PET MPI may be a...
ClinicalNewsAarhus University Hospital Documents Frequent Extracardiac Findings on 15O-Water PET Myocardial Perfusion ImagingAarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imaging From tumors and lung cancer to rib fractures and COVID-19 infiltrates. Researchers...
ClinicalNewsFirst Oncology Patient Scanned with 15O-Water on MedTrace EquipmentFirst Oncology Patient Scanned with 15O-Water on MedTrace Equipment MedTrace’s automated manufacturing system at the installation at The Department of Nuclear Medicine and Tracer Kinetics...
ClinicalNewsMedTrace Receives U.S. Patent for Diagnosing the Human HeartMedTrace Receives U.S. Patent for Diagnosing the Human Heart The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the...
NewsCEO Stepping Down; MedTrace Will Intensify Its Efforts to Complete the Phase 3 Clinical TrialCEO stepping down MedTrace will intensify its efforts to complete the phase 3 clinical trial MedTrace will intensify efforts to complete its phase 3 clinical...
ClinicalNews15O-Water Myocardial Perfusion Imaging: A Practical Approach to Simplifying the Gold Standard for Approved Clinical Use15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use Mark Lubberink, PhD, Scientific Advisor to MedTrace & Hendrik “Hans”...
